601628.SS
China Life Insurance Company Limited [601628.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
601628.SS Stock Summary
Top 10 Correlated ETFs
601628.SS
Top 10 Correlated Stocks
601628.SS
In the News
601628.SS Financial details
Company Rating
Buy
Market Cap
612.89B
Income
11.65B
Revenue
1096.39B
Book val./share
16.28
Cash/share
85.36
Dividend
0.49
Dividend %
1.9%
Employees
100K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
92.99
Forward P/E
-
PEG
-14.33
P/S
0.56
P/B
1.64
P/C
0.33
P/FCF
1.97
Quick Ratio
32.32
Current Ratio
32.32
Debt / Equity
0.58
LT Debt / Equity
0.1
-
-
EPS (TTM)
0.4
EPS next Y
-
EPS next Q
-
EPS this Y
-34.21%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-18.22%
Revenue last 5Y
2.6%
Revenue Q/Q
-76.14%
EPS Q/Q
-123.94%
-
-
-
-
SMA20
-3.45%
SMA50
-
SMA100
-9.68%
Inst Own
-
Inst Trans
-
ROA
-
ROE
2%
ROC
-
Gross Margin
100%
Oper. Margin
2%
Profit Margin
1%
Payout
399%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
25.09-43.0
52W High
-34.67%
52W Low
+12.36%
RSI
50
Rel Volume
1.07
Avg Volume
15.77M
Volume
16.81M
Perf Week
2.03%
Perf Month
-4.36%
Perf Quarter
-19.44%
Perf Half Y
-26%
-
-
-
-
Beta
0.814
-
-
Volatility
0.58%, 0.75%
Prev Close
-1.33%
Price
28.09
Change
2.26%
601628.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 25.81 | 28.48 | 29.17 | 28.44 | 29.34 | |
| Net income per share | 2.06 | 1.78 | 1.8 | 1.14 | 0.75 | |
| Operating cash flow per share | 10.12 | 10.76 | 10.13 | 12.45 | 13.74 | |
| Free cash flow per share | 9.72 | 10.49 | 9.94 | 12.34 | 13.59 | |
| Cash per share | 39.35 | 45.01 | 52.71 | 66.01 | 85.36 | |
| Book value per share | 14.29 | 15.92 | 16.93 | 15.43 | 16.28 | |
| Tangible book value per share | 14.21 | 15.88 | 16.93 | 15.46 | 16.33 | |
| Share holders equity per share | 14.29 | 15.92 | 16.93 | 15.43 | 16.28 | |
| Interest debt per share | 2.25 | 2.21 | 2.23 | 7.36 | 9.43 | |
| Market cap | 985.59B | 1085.09B | 850.49B | 1049.2B | 801.31B | |
| Enterprise value | 990.41B | 1085.68B | 845.92B | 970.94B | 700.72B | |
| P/E ratio | 16.91 | 21.59 | 16.75 | 32.7 | 37.96 | |
| Price to sales ratio | 1.35 | 1.35 | 1.03 | 1.31 | 0.97 | |
| POCF ratio | 3.45 | 3.57 | 2.97 | 2.98 | 2.06 | |
| PFCF ratio | 3.59 | 3.66 | 3.03 | 3.01 | 2.09 | |
| P/B Ratio | 2.44 | 2.41 | 1.78 | 2.41 | 1.74 | |
| PTB ratio | 2.44 | 2.41 | 1.78 | 2.41 | 1.74 | |
| EV to sales | 1.36 | 1.35 | 1.03 | 1.21 | 0.84 | |
| Enterprise value over EBITDA | 17.93 | 22.06 | 19.1 | 29.63 | 164.33 | |
| EV to operating cash flow | 3.46 | 3.57 | 2.95 | 2.76 | 1.8 | |
| EV to free cash flow | 3.61 | 3.66 | 3.01 | 2.78 | 1.82 | |
| Earnings yield | 0.06 | 0.05 | 0.06 | 0.03 | 0.03 | |
| Free cash flow yield | 0.28 | 0.27 | 0.33 | 0.33 | 0.48 | |
| Debt to equity | 0.15 | 0.13 | 0.12 | 0.47 | 0.58 | |
| Debt to assets | 0.02 | 0.01 | 0.01 | 0.04 | 0.05 | |
| Net debt to EBITDA | 0.09 | 0.01 | -0.1 | -2.39 | -23.59 | |
| Current ratio | 19.4 | 20.89 | 26.58 | 31 | 35.83 | |
| Interest coverage | 11.96 | 11.76 | 6.97 | 5.65 | 0 | |
| Income quality | 4.78 | 5.58 | 5.67 | 14.64 | 17.15 | |
| Dividend Yield | 0 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Payout ratio | 0.08 | 0.41 | 0.36 | 0.57 | 1.05 | |
| Sales general and administrative to revenue | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.04 | -0.02 | -0.02 | -0.01 | -0.01 | |
| Capex to revenue | -0.02 | -0.01 | -0.01 | 0 | -0.01 | |
| Capex to depreciation | -2.61 | -1.45 | -1.04 | -0.58 | -0.88 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 25.75 | 25.24 | 26.16 | 19.85 | 16.54 | |
| ROIC | 0.11 | 0.08 | 0.08 | 0.06 | 0 | |
| Return on tangible assets | 0.02 | 0.01 | 0.01 | 0.01 | 0 | |
| Graham Net | -78.42 | -92.35 | -111.66 | -115.24 | -106.34 | |
| Working capital | 1075.48B | 1234.51B | 1453.27B | 1824.58B | 2345.27B | |
| Tangible asset value | 401.51B | 448.88B | 478.65B | 437.03B | 461.67B | |
| Net current asset value | 2183.47B | 2498.89B | 2894.34B | 2921.47B | 3005.82B | |
| Invested capital | 0.15 | 0.13 | 0.12 | 0.47 | 0.58 | |
| Average receivables | 23.89B | 23.01B | 22.36B | 20.03B | 9.85B | |
| Average payables | 56.59B | 60.26B | 59.45B | 58.82B | 64.08B | |
| Average inventory | -27.54B | -132.88B | -361.93B | -587.57B | -330.97B | |
| Days sales outstanding | 10.84 | 11.04 | 9.01 | 8.94 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 33.68 | 33.05 | 40.5 | 40.82 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.14 | 0.11 | 0.11 | 0.07 | 0.05 | |
| Capex per share | -0.4 | -0.26 | -0.19 | -0.11 | -0.15 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.66 | 12.96 | 2.54 | 18.81 | 4.49 | |
| Net income per share | 0.03 | 0.63 | 0.31 | -0.71 | 0.17 | |
| Operating cash flow per share | 2.23 | 6.09 | 3.04 | 3.18 | 1.73 | |
| Free cash flow per share | 2.19 | 6.07 | 3.03 | -0.59 | 1.65 | |
| Cash per share | 66.01 | 71.19 | 101.98 | 77.92 | 85.36 | |
| Book value per share | 15.43 | 16.31 | 16.91 | 15.63 | 16.28 | |
| Tangible book value per share | 15.46 | 16.34 | 192.83 | 15.68 | 16.33 | |
| Share holders equity per share | 15.43 | 16.31 | 16.91 | 15.63 | 16.28 | |
| Interest debt per share | 7.19 | 3.23 | 6.23 | 5.96 | 9.43 | |
| Market cap | 1049.2B | 940.94B | 988.14B | 1024.89B | 801.31B | |
| Enterprise value | 970.94B | 991.52B | 841.26B | 880.17B | 700.72B | |
| P/E ratio | 271.81 | 13.15 | 28.06 | -12.85 | 40.87 | |
| Price to sales ratio | 10.14 | 2.57 | 13.78 | 1.93 | 6.32 | |
| POCF ratio | 16.62 | 5.46 | 11.5 | 11.39 | 16.4 | |
| PFCF ratio | 16.98 | 5.49 | 11.56 | -60.99 | 17.18 | |
| P/B Ratio | 2.41 | 2.04 | 2.07 | 2.32 | 1.74 | |
| PTB ratio | 2.41 | 2.04 | 2.07 | 2.32 | 1.74 | |
| EV to sales | 9.39 | 2.71 | 11.73 | 1.66 | 5.52 | |
| Enterprise value over EBITDA | -145.5 | 52.69 | 566.12 | -25.22 | 555.69 | |
| EV to operating cash flow | 15.38 | 5.76 | 9.79 | 9.78 | 14.34 | |
| EV to free cash flow | 15.72 | 5.78 | 9.84 | -52.38 | 15.02 | |
| Earnings yield | 0 | 0.02 | 0.01 | -0.02 | 0.01 | |
| Free cash flow yield | 0.06 | 0.18 | 0.09 | -0.02 | 0.06 | |
| Debt to equity | 0.47 | 0.11 | 0.45 | 0.38 | 0.58 | |
| Debt to assets | 0.04 | 0.01 | 0.04 | 0.03 | 0.05 | |
| Net debt to EBITDA | 11.73 | 2.69 | -98.85 | 4.15 | -79.77 | |
| Current ratio | 31 | 29.04 | 41.75 | 32.32 | 35.83 | |
| Interest coverage | 0 | 1.45 | -0.04 | 0 | 0 | |
| Income quality | 65.43 | 9.63 | -49.71 | 1.7K | 9.97 | |
| Dividend Yield | 0.01 | 0 | 0 | 0.02 | 0 | |
| Payout ratio | 6.28 | 0.19 | 0.18 | -1.01 | 0.42 | |
| Sales general and administrative to revenue | 0.12 | 0.03 | 0.14 | 0.02 | 0.09 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.02 | 0 | -0.01 | -1.19 | -0.05 | |
| Capex to revenue | -0.01 | 0 | -0.01 | -0.2 | -0.02 | |
| Capex to depreciation | -1.14 | -0.63 | -0.38 | -93.32 | -1.93 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.44 | 15.24 | 10.89 | 15.75 | 7.97 | |
| ROIC | 0 | 0.11 | 0 | -0.04 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | -115.24 | -108.3 | 90.34 | -111.9 | -106.34 | |
| Working capital | 1824.58B | 2060.64B | 2813.42B | 2263.38B | 2345.27B | |
| Tangible asset value | 437.03B | 461.83B | 5450.47B | 443.13B | 461.67B | |
| Net current asset value | 2921.47B | 2858.18B | 2834.12B | 2972.25B | 3005.82B | |
| Invested capital | 0.47 | 0.11 | 0.45 | 0.38 | 0.58 | |
| Average receivables | 9.85B | 70.78B | 72.71B | 78.41B | 66.62B | |
| Average payables | 61.26B | 67.15B | 71.26B | 70.66B | 69.81B | |
| Average inventory | -330.97B | -503.49B | -470.94B | -455.68B | -157.26B | |
| Days sales outstanding | 17.14 | 29.95 | 29.58 | 22.56 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 5.25 | 3.01 | 3.04 | 3.99 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0.04 | 0.02 | -0.05 | 0.01 | |
| Capex per share | -0.05 | -0.03 | -0.02 | -3.78 | -0.08 |
601628.SS Frequently Asked Questions
What is China Life Insurance Company Limited stock symbol ?
China Life Insurance Company Limited is a CN stock and trading under the symbol 601628.SS
What is China Life Insurance Company Limited stock quote today ?
China Life Insurance Company Limited stock price is $28.09 today.
Is China Life Insurance Company Limited stock public?
Yes, China Life Insurance Company Limited is a publicly traded company.
Company Profile
- Volume Average 15.77M
- Market Capitalization 612.89B
- Employee 100K
- CEO Dr. Tao Bai Ph.D.
- Headquarters Beijing,CN
- IPO Date 2007-01-09
-
Website
https://www.e-chinalife.com 
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China. The company operates in four segments: Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses. It offers critical illness protection, annuity, children/women/pension, security, life, medical, and accident protection insurance products. The company was founded in 1949 and is based in Beijing, the People's Republic of China. China Life Insurance Company Limited is a subsidiary of China Life Insurance (Group) Company Limited.
